Nachrichten zur Iovance Biotherapeutics Inc. Aktie

Stocks to Watch: EzFill, Better Therapeutics, Iovance Biotherapeutics, E2open

Stocks to Watch: EzFill, Better Therapeutics, Iovance Biotherapeutics, E2open...…

Iovance Biotherapeutics Shares Fall After News of Planned Public Offering

Iovance Biotherapeutics Shares Fall After News of Planned Public Offering...…

Iovance Biotherapeutics proposes $150M stock offering, shares fall 9% after hours

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics, Inc. Announces Proposed Public Offering of Common Stock

SAN CARLOS, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology…

FMC, Outset Medical fall; Iovance, Helen of Troy rise, Monday, 7/10/2023

Stocks that are trading heavily or have substantial price changes Monday: FMC, Outset Medical fall; Iovance, Helen of Troy rise...…

Iovance Biotherapeutics Shares Rise 12% After Positive Lung Cancer Therapy Trial Data

Iovance Biotherapeutics Shares Rise 12% After Positive Lung Cancer Therapy Trial Data...…

Iovance receives FDA feedback on lung cancer candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics Announces Regulatory and Clinical Updates for TIL Therapy in Advanced Non-Small Cell Lung Cancer

Positive FDA Feedback Supports IOV-LUN-202 Trial Design for Accelerated Approval of TIL Therapy in Post-Anti-PD-1 Advanced Non-Small Cell Lung Cancer (NSCLC)...…

Barclays bullish on Biomea, Replimune, Syndax, Iovance for 2H 2023

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 16

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance (IOVA) Updates on Combo Drug in Advanced Melanoma Study

Iovance (IOVA) announces randomizing the first patient in the TILVANCE-301 study evaluating the safety and efficacy of its lifileucel/Keytruda combo…

Iovance Biotherapeutics Announces First Patient Randomized in Phase 3 TILVANCE-301 Trial in Frontline Advanced Melanoma

Global Trial of Iovance TIL Therapy Lifileucel in Combination with Pembrolizumab Global Trial of Iovance TIL Therapy Lifileucel in Combination…

Iovance Biotherapeutics to Present at Jefferies Global Healthcare Conference

SAN CARLOS, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company…

Why Is Iovance Biotherapeutics (IOVA) Up 7.9% Since Last Earnings Report?

Iovance Biotherapeutics (IOVA) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K/A IOVANCE BIOTHERAPEUTICS, For: May 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Why Shares of Iovance Biotherapeutics Jumped Tuesday

The company received approval for a biologics license application for an advanced melanoma therapy....…

Iovance rises as Wall Street reacts to FDA priority review for melanoma drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Stocks to Watch: Iovance Biotherapeutics, Lexicon Pharmaceuticals

Stocks to Watch: Iovance Biotherapeutics, Lexicon Pharmaceuticals...…

Iovance Shares Shares Get After-Hours Boost From FDA Approval

Iovance Shares Shares Get After-Hours Boost From FDA Approval...…

Iovance up 15% on FDA acceptance of lifileucel application for melanoma

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics Announces U.S. Food and Drug Administration Acceptance of the Biologics License Application of Lifileucel for the Treatment of Advanced Melanoma

Priority Review Granted withPrescription Drug User Fee Act (PDUFA) Action Date of November 25, 2023...…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: May 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q IOVANCE BIOTHERAPEUTICS, For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance (IOVA) Posts Narrower-Than-Expected Loss in Q1

Iovance (IOVA) reports Q1 earnings that beat our estimates. The companys acquisition of IL-2 product Proleukin is expected to close…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Apr 18

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics to Present at Upcoming Conferences

SAN CARLOS, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company…

Why Shares of Iovance Biotherapeutics Jumped Monday

The company filed a Biologics License Application to the FDA for its lead therapy....…

Iovance (IOVA) Completes Rolling BLA Filing for Melanoma Drug

Following the completion of Iovances (IOVA) regulatory filing for its lead candidate in melanoma indication, the FDA has 60 days…

Iovance Biotherapeutics submits BLA to FDA for advanced melanoma drug lifileucel

A tumour infiltrating lymphocyte (TIL) therapy, lifileucel is designed to treat patients with advanced (unresectable or metastatic) melanoma who advanced on…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Mar 24

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics completes license application submission for advanced melanoma therapy; shares rally

Biotech cancer-treatment developer Iovance Biotherapeutics Inc. IOVA on Friday said it had completed its rolling biologics license application submission to…

Stocks to Watch: Motorsport Games, Berkshire Grey, Iovance Biotherapeutics

Stocks to Watch: Motorsport Games, Berkshire Grey, Iovance Biotherapeutics...…

Iovance up 13% on completing Biologics License Application submission for lifileucel

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics Up After Hours, Lifileucel Application Submission Completed

Iovance Biotherapeutics Up After Hours, Lifileucel Application Submission Completed...…

Iovance Biotherapeutics Completes Biologics License Application (BLA) Submission for Lifileucel in Advanced Melanoma

First TIL Therapy BLA Submission to U.S. Food and Drug Administration First TIL Therapy BLA Submission to U.S. Food and…

Cara, Iovance, and Karyopharm among biotechs with no exposure to SVB

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Mar 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance (IOVA) Q4 Earnings In Line With Estimates, Revenues Nil

Iovance (IOVA) reports Q4 earnings in line with our estimates. Management is on track to complete the rolling BLA submission…

Iovance Biotherapeutics stock price target cut to $15 from $25 at Oppenheimer

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-K IOVANCE BIOTHERAPEUTICS, For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates

First Biologics License Application (BLA) Submission on Track to Complete in 1Q23 First Biologics License Application (BLA) Submission on Track…

Iovance Biotherapeutics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call and Webcast on Tuesday, February 28, 2023

SAN CARLOS, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company…

dpa-AFX ProFeed